Anne F Luetkemeyer Selected Research

Tuberculosis (Tuberculoses)

8/2017	Impact of Larger Sputum Volume on Xpert® MTB/RIF Assay Detection of Mycobacterium tuberculosis in Smear-Negative Individuals with Suspected Tuberculosis.
5/2016	Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.
4/2014	Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs.
4/2014	Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB.
8/2013	Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study.
10/2011	Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.
5/2011	Complications of HIV disease and antiretroviral therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne F Luetkemeyer Research Topics

Disease

17	Infections 07/2023 - 10/2010
8	COVID-19 07/2022 - 01/2020
7	Sexually Transmitted Diseases (Sexually Transmitted Disease) 04/2024 - 01/2020
7	HIV Infections (HIV Infection) 06/2021 - 05/2011
7	Coinfection 01/2021 - 05/2011
7	Tuberculosis (Tuberculoses) 08/2017 - 05/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 05/2011
4	Fibrosis (Cirrhosis) 01/2018 - 01/2016
4	Hepatitis 05/2017 - 04/2013
4	Opportunistic Infections (Opportunistic Infection) 05/2014 - 05/2011
3	Hepatitis C 01/2022 - 07/2014
3	Acquired Immunodeficiency Syndrome (AIDS) 08/2015 - 05/2011
2	Syphilis 04/2023 - 01/2020
2	Reinfection 01/2022 - 04/2019
2	Vitamin D Deficiency 04/2013 - 06/2012
2	Lipodystrophy 06/2012 - 05/2011
1	Non-alcoholic Fatty Liver Disease 11/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2023
1	Opioid-Related Disorders (Opiate Addiction) 07/2023
1	Gonorrhea 04/2023
1	Pneumonia (Pneumonitis) 12/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2021
1	Fatty Liver 06/2021
1	Hepatocellular Carcinoma (Hepatoma) 06/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Chronic Hepatitis C 01/2018
1	Hepatitis B 05/2017
1	Pulmonary Tuberculosis 05/2016
1	Aortitis 08/2015
1	Immune Reconstitution Inflammatory Syndrome 04/2014
1	Virus Diseases (Viral Diseases) 04/2013
1	Viremia 11/2011
1	Neoplasms (Cancer) 05/2011

Drug/Important Bio-Agent (IBA)

11	Antiviral Agents (Antivirals)IBA 07/2023 - 05/2011
7	Doxycycline (Periostat)FDA LinkGeneric 04/2024 - 01/2020
4	RNA (Ribonucleic Acid)IBA 11/2023 - 07/2014
4	InterferonsIBA 12/2021 - 05/2014
4	SofosbuvirIBA 01/2021 - 07/2014
3	AcidsIBA 08/2017 - 04/2014
3	Nucleic AcidsIBA 08/2017 - 04/2014
3	Rifampin (Rifampicin)FDA LinkGeneric 05/2016 - 08/2013
2	Opioid Analgesics (Opioids)IBA 07/2023 - 01/2022
2	remdesivirIBA 12/2021 - 01/2021
2	Oxygen (Dioxygen)IBA 12/2021 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 05/2016
2	glecaprevir and pibrentasvirIBA 01/2021 - 01/2018
2	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 07/2014
2	Isoniazid (Ftivazide)FDA LinkGeneric 04/2014 - 10/2010
2	Biomarkers (Surrogate Marker)IBA 04/2013 - 06/2012
1	HDL CholesterolIBA 11/2023
1	C-Reactive ProteinIBA 11/2023
1	pitavastatin (itavastatin)FDA Link 11/2023
1	elbasvirIBA 07/2023
1	grazoprevirIBA 07/2023
1	Tetracycline (Achromycin)FDA LinkGeneric 04/2023
1	VaccinesIBA 01/2023
1	mRNA VaccinesIBA 07/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 07/2022
1	ChAdOx1 nCoV-19IBA 01/2022
1	Interferon beta-1a FDA Link 12/2021
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2021
1	baricitinibIBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2020
1	sofosbuvir drug combination ledipasvirIBA 01/2018
1	glecaprevirIBA 01/2018
1	pibrentasvirIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 05/2017
1	Tenofovir (Viread)FDA Link 05/2017
1	Ritonavir (Norvir)FDA Link 01/2017
1	Darunavir (Prezista)FDA Link 01/2017
1	Atazanavir Sulfate (Reyataz)FDA Link 01/2017
1	Raltegravir Potassium FDA Link 01/2017
1	dasabuvirIBA 01/2017
1	ombitasvirIBA 01/2017
1	paritaprevirIBA 01/2017
1	dolutegravirIBA 01/2017
1	GoldIBA 05/2016
1	Tuberculin (PPD)IBA 05/2016
1	Culture MediaIBA 05/2016
1	DNA VaccinesIBA 02/2016
1	daclatasvirIBA 01/2016
1	16S Ribosomal RNAIBA 08/2015
1	Interferon-alpha (Interferon Alfa)IBA 03/2015
1	Protease Inhibitors (Protease Inhibitor)IBA 05/2014
1	efavirenz (Sustiva)FDA Link 08/2013
1	entecavir FDA Link 11/2011

Therapy/Procedure

15	Therapeutics 07/2023 - 10/2010
3	Art Therapy 11/2023 - 10/2011
3	Aftercare (After-Treatment) 01/2022 - 01/2018
2	Retreatment 01/2018 - 05/2016
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Opiate Substitution Treatment 01/2022
1	Liver Transplantation 01/2021
1	Duration of Therapy 01/2021
1	Noninvasive Ventilation 01/2021
1	Condoms (Condom) 01/2020